Quick Facts
FONT-SIZE Plus   Neg
Share SHARE

CytoDyn Appoints Nader Pourhassan As Interim CEO - Quick Facts

CytoDyn Inc. (CYDY: Quote) announced the appointment of Nader Pourhassan as its new interim Chief Executive Officer and Richard Trauger as its new Chief Scientific Officer.

Pourhassan brings over 20 years of advanced engineering and mathematics expertise as well as strong business acumen, to his new role. Prior to his new position as CEO, Pourhassan served as the Company's Managing Director of Business Development, and before that, as its Chief Operating Officer. He succeeds former President and CEO Kenneth Van Ness.

The appointment of Pourhassan to CEO follows the recent promotion of Richard Trauger from Managing Director of Science to Chief Scientific Officer on August 23, 2012.

Click here to receive FREE breaking news email alerts for CYTODYN INC and others in your portfolio

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Quick Facts

Editors Pick
Computer and printer maker Hewlett-Packard Co. said Tuesday after the markets closed that its fourth quarter profit fell 6% from last year, as revenue declined 2%. The company's quarterly earnings per share, excluding items, came in line with analysts' expectations, but its quarterly revenue fell short of analysts' forecast. This organic and natural products company has experienced strong compounded annual growth over the last four fiscal years with its net sales growing 25% and adjusted income from continuing operations over 30%. Here is a quick summary of the earnings reported after the bell on Nov. 24. 1. Amira Nature Foods Ltd (ANFI) reported net income for the second quarter of $8.3 million or $0.29 per share, compared to $5.0 million or $0.18 per share for the year-ago quarter. Excluding items, adjusted earnings...
comments powered by Disqus
FREE Newsletters, Analysis & Alerts

 

Stay informed with our FREE daily Newsletters and real-time breaking News Alerts. Sign up to receive the latest information on business news, health, technology, biotech, market analysis, currency trading and more.